<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: It has long been debated whether <z:e sem="disease" ids="C0236792" disease_type="Disease or Syndrome" abbrv="">Asperger's Syndrome</z:e> (ASP) should be considered part of the <z:hpo ids='HP_0000729'>Autism Spectrum Disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e>) or whether it constitutes a unique entity </plain></SENT>
<SENT sid="1" pm="."><plain>The Diagnostic and Statistical Manual, fourth edition (<z:chebi fb="4" ids="38624">DSM</z:chebi>-IV) differentiated ASP from high functioning <z:hpo ids='HP_0000717'>autism</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the new <z:chebi fb="4" ids="38624">DSM</z:chebi>-5 umbrellas ASP within <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e>, thus eliminating the ASP diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>To date, no clear biomarkers have reliably distinguished ASP and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> populations </plain></SENT>
<SENT sid="4" pm="."><plain>This study uses EEG coherence, a measure of brain connectivity, to explore possible neurophysiological differences between ASP and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Voluminous coherence data derived from <z:hpo ids='HP_0000001'>all</z:hpo> possible electrode pairs and frequencies were previously reduced by principal components analysis (<z:chebi fb="20" ids="36751">PCA</z:chebi>) to produce a smaller number of unbiased, data-driven coherence factors </plain></SENT>
<SENT sid="6" pm="."><plain>In a previous study, these factors significantly and reliably differentiated neurotypical controls from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> subjects by discriminant function analysis (<z:chebi fb="0" ids="23716">DFA</z:chebi>) </plain></SENT>
<SENT sid="7" pm="."><plain>These previous <z:chebi fb="0" ids="23716">DFA</z:chebi> rules are now applied to an ASP population to determine if ASP subjects classify as control or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> subjects </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, a new set of coherence based <z:chebi fb="0" ids="23716">DFA</z:chebi> rules are used to determine whether ASP and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> subjects can be differentiated from each other </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Using prior EEG coherence based <z:chebi fb="0" ids="23716">DFA</z:chebi> rules that successfully classified subjects as either controls or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e>, 96.2% of ASP subjects are classified as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>However, when ASP subjects are directly compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> subjects using new <z:chebi fb="0" ids="23716">DFA</z:chebi> rules, 92.3% ASP subjects are identified as separate from the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> population </plain></SENT>
<SENT sid="11" pm="."><plain>By contrast, five randomly selected subsamples of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> subjects fail to reach significance when compared to the remaining <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> populations </plain></SENT>
<SENT sid="12" pm="."><plain>When represented by the discriminant variable, both the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> populations are normally distributed </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Within a control-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> dichotomy, an ASP population <z:hpo ids='HP_0002527'>falls</z:hpo> closer to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> than controls </plain></SENT>
<SENT sid="14" pm="."><plain>However, when compared directly with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e>, an ASP population is distinctly separate </plain></SENT>
<SENT sid="15" pm="."><plain>The ASP population appears to constitute a neurophysiologically identifiable, normally distributed entity within the higher functioning tail of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e> population distribution </plain></SENT>
<SENT sid="16" pm="."><plain>These results must be replicated with a larger sample given their potentially immense clinical, emotional and financial implications for affected individuals, their families and their caregivers </plain></SENT>
</text></document>